Literature DB >> 31752713

Clinical effect of T-SPOT.TB test for the diagnosis of tuberculosis.

Yanfen Ma1, Ruicheng Li2, Jinghui Shen3, Longmei He4, Ying Li5, Ning Zhang1, Qian Wu1, Jinling Zhang6, Jie Zheng7, Xiaoqin Wang8.   

Abstract

BACKGROUND: The goal of this study was to further investigate the clinical effectiveness of the T-SPOT.TB test in diagnosing tuberculosis (TB), including the effects of T-SPOT.TB test on evaluating diverse TB types and locations.
METHODS: We collected 20,332 specimens from patients suspected to have TB. Afterwards, we performed an integrative analysis of T-SPOT.TB results and clinical diagnoses, and evaluated the composition ratio and positive detection rate of the T-SPOT.TB test in various age groups, sample types, and hospital departments. In addition, we compared the spot number and composition rate between latent TB infection (LTBI), active TB infection, and old TB infection groups. The active TB group was then further divided into pulmonary TB (PTB), pulmonary and extrapulmonary TB (PETB), and extrapulmonary TB (EPTB) subgroups, and we evaluated whether there were statistical differences in spot number and composition rate between subgroups.
RESULTS: Positive results from the T-SPOT.TB test were found across different age groups, specimen types, and hospital departments. Elderly patient groups, pleural effusion samples, and thoracic surgery departments showed the highest rates of positivity. There were no statistically significant differences in spot number of CFP-10 and ESAT-6 wells between disease groups or active TB subgroups. The composition rate, however, was significantly different when ESAT-6 and CFP-10 wells were double-positive. The spot number and composition rate were statistically different between the three disease groups, but showed no significant differences between the three subgroups of active TB.
CONCLUSIONS: The results of T-SPOT. TB test showed differences in LTBI, active TB and old TB. Additionally, a higher spot number level was observed in the active TB group.

Entities:  

Keywords:  Active tuberculosis; Clinical diagnosis; Mycobacterium tuberculosis; T cell spot test of tuberculosis infection

Year:  2019        PMID: 31752713     DOI: 10.1186/s12879-019-4597-8

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  7 in total

1.  Analysis of Negative Results of Metagenomics Next-Generation Sequencing in Clinical Practice.

Authors:  Mengjia Qian; Bijun Zhu; Yanxia Zhan; Lingyan Wang; Qi Shen; Miaomiao Zhang; Lei Yue; Duojiao Wu; Hao Chen; Xiangdong Wang; Yunfeng Cheng
Journal:  Front Cell Infect Microbiol       Date:  2022-05-16       Impact factor: 6.073

Review 2.  Measuring single-cell protein secretion in immunology: Technologies, advances, and applications.

Authors:  Olivia T M Bucheli; Ingibjörg Sigvaldadóttir; Klaus Eyer
Journal:  Eur J Immunol       Date:  2021-04-01       Impact factor: 5.532

3.  Factors associated with differential T cell responses to antigens ESAT-6 and CFP-10 in pulmonary tuberculosis patients.

Authors:  Shengsheng Liu; Meiying Wu; Ertai A; Shucai Wu; Shujun Geng; Zhihui Li; Mingwu Li; Liang Li; Yu Pang; Wanli Kang; Shenjie Tang
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

4.  Primary adrenal insufficiency due to adrenal tuberculosis: a case report.

Authors:  Jie Yu; Yingli Lu; Bing Han
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

5.  Accuracy of multitarget indirect enzyme-linked immunoassay assay for detection of tuberculosis antibody.

Authors:  Yang Hu; Ming Liu; Haili Hu; Hua Yang; Lianhua Qin; Zhongyi Hu; Changtai Zhu; Zhonghua Liu
Journal:  Ann Transl Med       Date:  2021-12

6.  Immune status changing helps diagnose osteoarticular tuberculosis.

Authors:  Tuo Liang; Jiarui Chen; GuoYong Xu; Zide Zhang; Jiang Xue; Haopeng Zeng; Jie Jiang; Tianyou Chen; Zhaojie Qin; Hao Li; Zhen Ye; Yunfeng Nie; Chong Liu; Xinli Zhan
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

7.  Use of Rv0222-Rv2657c-Rv1509 Fusion Protein to Improve the Accuracy of an Antibody ELISA for Extra-Pulmonary Tuberculosis in Humans.

Authors:  Yingyu Chen; Pan Ge; Kailun Zhang; Jie Xiang; Li Zhang; Ian D Robertson; Aizhen Guo
Journal:  Pathogens       Date:  2021-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.